Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5430_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
10.10.2026
Размер:
10 Мб
Скачать
☆
104
Metals in Medicine, Volume 2




101–103

  
         
     

         
      
    
  -
          



       -


2

         
to combat cancer using the HeLa (cervical malignant cell line) and normal

CeO
2


  
       




    

      


104,105
https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
105


   



      

contemporary therapeutic approaches extend remission in CLL patients, this

physical qualities, such as their high photoluminescence and biocompati-

   

-



       
          

-



   


106,107
3.7 ZnO NPS IN DIAGNOSIS OF OTHER DISEASES AS WELL AS
ANALYTES
        
-


       


https://t.me/med1917
106
Metals in Medicine, Volume 2
    
 

        
          
       

viruses, may be detected using electrochemical biosensors constructed on
three-dimensional ZnO nanostructures.
108

parasite Toxoplasma gondii (T. gondii   -

Although the illness is typically asymptomatic, it has the potential to result
in local lymphadenopathy , immunocompromised adults dying, and neonates
developing hydrocephalus,choriogenins, microcephaly, intracranial calci-
         
       


      -
     T. gondii
T. gondii-CH-ZnO NPs)
IgG anti-T. gondii -
T. gondii

-


109
           



or cyanide poisoning, heart or liver diseases, and in particular, the physical

the dairy and alcoholic beverage industries, sports medications, and degrad-

     
-

https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
107



    
mM detection threshold.
110

Aedes aegypti
     
       
  
        
      
antibody to build an electrochemical immunosensor based on printed circuit


-


-
        


0.1 ng mL
–1
to 100 ng mL
–1

–1
.
Since it is portable, reasonably priced, and simple to use, the biosensor is

111







    -
 





https://t.me/med1917
108
Metals in Medicine, Volume 2
   
leads to improved sensing characteristics. Au nanoparticles can be used as a
catalyst to break apart molecular oxygen. More reactive oxygen is produced
        

112
Dopamine is a crucial catecholamine neurotransmitter molecule in the


      

        


     



      

113

   


urine catheters, prosthetic joints, dental implants, contact lenses, and central
       -


            

causing ROS production, Zn

ion release, H
2
O
2
ion accumulation, and simple

114
3.8 TOXICITY OF ZnO NPS
-
        
    
         
       
https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
109

       
      
 
    
115
It has been observed that ZnO
NPs are extremely reactive and cause single-stranded DNA breaks caused by

  


    
       
        


92
        
   






       


      
concentration dose measurements.
116
-

        

       


117
E. coli or
S. aureus
   
therapeutic dose regimens.
118
https://t.me/med1917
110
Metals in Medicine, Volume 2
3.9 CONCLUSION AND FUTURE DIRECTIONS
         
      
and therapeutic approaches made possible by nanotechnology have revolu-
-
 
Due to their distinct electrical, optical, mechanical, magnetic, and chemical
capabilities, ZnO NPs stand out among other metal oxide nanoparticles in

         
ZnO NPs as being secure. It has been used in several biological applications,
  



         



proteins it can easily detect the desired biomarker and more over ZnO NPs
        

    




KEYWORDS
• ZnO NPs
• early diagnosis
• Alzheimer’s disease
• cancer
https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
111
REFERENCES
 .
Nanoparticles 2017, 6 (3), 93–102.
 
Int. J.
Mol. Sci. 2022, 23 (1).
 
Clin. Chim. Acta 2009, 403
 
Appl. Biochem. Biotechnol. 2011, 165 (5–6), 1178–87.
        
Nano
Converg. 2016, 3 (1), 1–14.
          
Nanomedicine 2009, 4 (1), 83–103.
 
Oxid.
Med. Cell Longev. 2018, 2018.
 
Imaging. Nanoscale 2019, 11 (3), 799–819.
 Zinc Soils Plants
      
Copper. Nontraditional Stable Isot. 2017, 82, 543–600.
11. King, J. C. Zinc: An Essential but Elusive Nutrient. Am. J. Clin. Nutr. 2011, 94 (2),
679–684.
12. Jain, K K. Nanotechnology in Clinical Laboratory Diagnostics. Clin. Chim. Acta 2005,
358 (1–2), 37–54.
         
Nanoparticles. In Inorganic Frameworks as Smart Nanomedicines

 

Compatibility. Acta Biomater. 2019, 97,  
actbio.2019.07.038
           
Human Health: An Update. Arch. Toxicol. 2012, 86 (4), 521–534.
 
J. Nutr. Sci. Vitaminol. (Tokyo) 2018, 64 (1), 1–7.
       
Nutrients 2020, 12 (3), 1–45.
 
Element. Arch. Toxicol. 2006, 80 (1), 1–9.
            
Nutrients 2018, 10 (2).
https://t.me/med1917
112
Metals in Medicine, Volume 2
          
Gastroenterology 2009,     
gastro.2009.08.014
    
Biol. Trace Elem. Res. 2021, 199 (8),
2882–2892.
 

Biol. Trace Elem. Res. 2018, 183 (1), 1–8.
 
2020, 37 (4), 428–441.
      Kirk-Othmer Encycl. Chem. Technol. 2017,
(November), 1–13.
 
Can. Fam. Physician. 1998, 44 (May), 1037–1042.
 
Gluconate and the Common Cold: A Controlled Clinical Study. J. Int. Med. Res. 1992,
20 (3), 234–246.
 
J.
Dent. Res. 2005, 84 (1), 35–38.
 
Skin Epithelia. Int. J. Mol. Sci. 2021, 22 (18), 1–30.
 
     Fish
Physiol. Biochem. 2019, 45 (4), 1495–1512.
         
Applications. Int. J. Cosmet. Sci. 2018, 40 (4), 319–327.
 Drug Dev.
Ind. Pharm. 1990, 16 (16), 2409–2429.
 
 Coord.
Chem. Rev. 2003, 246 (1–2), 145–168.
33. Simkin, P. A. Oral Zinc Sulphate in Rheumatoid Arthritis. Lancet 1976, 308 (7985),
539–542.
 
J. Neurol. Sci. 1987,
77 (2–3), 137–146.
      
  Clin. Exp. Dermatol. 2001, 26 (1),
21–26.
 
 Biol.
Trace Elem. Res. 2020, 198 (1), 109–117.
 
     Implant Dent. 2007, 16 (1),
89–100.
https://t.me/med1917
Zinc Oxide Nanoparticles in Disease Diagnosis
113
 2012.
       Handbook on the Toxicology of
Metals         
b978-0-444-59453-2.00033-0
         
   J. Am. Acad. Dermatol. 1990, 22   

            Expert Opin.
Pharmacother. 2001, 2 (9), 1473–1477.
        
Applications. J. Bioelectron. Nanotechnol. 2016, 1 (1), 1–5.
           

 2013, 41 (6), 645–649.
45. Chemotherapy IFOR. Hemoglobin Drop Alarmingly. 2015, 92 (July 13).
 
Nanotechnol. Rev. 2011.
 
Int. J. Environ. Health Res. 2022, 32
020.1805415
 
Mater Res Soc Symp—Proc. 1997, 452, 389–394.
 
Jordan J. Phys. 2020, 13 (2), 123–135.
 
Reference Module in Materials Science
and Materials Engineering      
b978-0-12-803581-8.11585-1
 
     
Applications. Nanomaterials 2022, 12 (17).
 
Mater. Today Proc. 2021, 47 (Xxxx), 3554–3559.

 
    Iran. J. Chem.
Chem. Eng. 2018, 37 (1), 11–16.
 
ZnO by Wet-Etching Using Acidic Solutions. J. Nanosci. Nanotechnol. 2006, 6 (11),
3364–3368.
      

Chem. Vap. Depos. 2011, 17 (10–12), 337–341.
         
     Procedia Chem. 2016, 19

https://t.me/med1917